Monstar Lab, Inc. (5255.T)

Monstar Lab, Inc. (5255.T) — VMCI valuation read

Headline read on 5255.T: VMCI of 31/100 versus a Technology sector median of 50. The 19-point below-median position is what makes Monstar Lab, Inc. a relative-value laggard in the mid-cap cohort, before any pillar-level review.

Form 4 filings on 5255.T: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.

**Investor frame.** Three reads on 5255.T: value (5255.T trades at 15.0x earnings, 17% below the Technology median of 18.0x), quality (ROIC of 11.0% sits 1.0pp above the Technology median (10.0%)), and risk (net debt to EBITDA of 2.0x is the rate-sensitivity line to watch). The value read also implies an EV/EBITDA gap of +4.0x against the Technology 12.0x baseline.

5255.T fell 1.8% over the trailing 7 days, with a -0.6% read on a 30-day basis.